ABLS
Abacus FCF Small Cap Leaders ETF
Abacus FCF Small Cap Leaders ETF seeks to provide investors with long-term capital appreciation by investing in a concentrated portfolio of small-cap companies with strong free cash flow generation.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 1.2 M
ASSETS UNDER MGMT
59 bp
EXPENSES
Fund Basics
| Inception date | Feb 18, 2025 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ARGAN INC | 17.0 % |
| ENOVA INTERNATIONAL INC | 4.5 % |
| ARTISAN PARTNERS ASSET MA -A | 4.5 % |
| COLLEGIUM PHARMACEUTICAL, INC. | 4.3 % |
| HEALTHCARE SERVICES GROUP | 3.8 % |
| OSCAR HEALTH, INC. CLASS A | 3.4 % |
| HARMONY BIOSCIENCES HOLDINGS, INC. | 3.3 % |
| LCI INDUSTRIES | 3.1 % |
| PJT PARTNERS, INC. CLASS A | 3.1 % |
| ARLO TECHNOLOGIES, INC. | 2.8 % |
Constituent Breakdown
| Number of holdings | 50 |
| Herfindahl-Hirschman Index | 487 |
| Wgt avg mkt cap (mns) | $2,840 |
| Large cap (>$10bn) | 1.9% |
| Mid cap ($2-10bn) | 59.9% |
| Small cap (<$2bn) | 38.0% |
| Developed mkts. | 99.7% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 97.5 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -8.3% | -19.5% | -- | -- | -- | -- | -- | -24.1% |
| Dividend Yield | 0.1% | 11.1% | -- | -- | -- | -- | -- | 9.4% |
| Total Returns | -8.2% | -8.4% | -- | -- | -- | -- | -- | -14.7% | Ann. Volatility | 20.9% | 20.8% | -- | -- | -- | -- | -- | 20.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.77 | 50% |
| MSCI EAFE | 0.72 | 38% |
| MSCI Emg Mkts | 0.57 | 30% |
Liquidity Measures
| Avg. volume (000) | 1 |
| ADV traded (mns) | $0 |
| Turnover | 1.7% |
| Avg. Bid/Ask (% of price) | 0.28% |
Technical Indicators
| 30d moving avg. (EMA) | $19.21 |
| Relative strength (RSI) | 59 |
| MACD/Signal | 0.39/0.26 |
| Bollinger Bands (Upper/Lower) | $20.50/$17.87 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. ABLS |
Expenses vs. ABLS |
ALTAR Score™ vs. ABLS |
|---|---|---|---|---|
| JSML | Janus Henderson Small Cap Growth Alpha ETF | 19.3% | -29 bp | -2.2% |
| JSMD | Janus Henderson Small/Mid Cap Growth Alpha ETF | 14.0% | -29 bp | -1.1% |
| SIXS | ETC 6 Meridian Small Cap Equity ETF | 13.5% | +30 bp | +2.2% |
| CAFG | Pacer US Small Cap Cash Cows Growth Leaders ETF | 11.9% | 0 bp | -1.1% |
| XSHQ | Invesco S&P SmallCap Quality ETF | 10.9% | -30 bp | +1.4% |
Risk and Returns: ABLS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/30/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.3%
ALTAR SCORE™
65th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,199 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. ABLS's ALTAR Score™ is approximately 0.4 standard
deviations above the category average. This places ABLS in the 65th percentile
among funds in the category.
Sell-Side Consensus
$23.26
PRICE TARGET
+16.6%
UPSIDE